Bortezomib as salvage treatment for heavily pretreated relapsed lymphoma patients: a multicenter retrospective study.

@article{Zinzani2013BortezomibAS,
  title={Bortezomib as salvage treatment for heavily pretreated relapsed lymphoma patients: a multicenter retrospective study.},
  author={Pier Luigi Zinzani and Cinzia Pellegrini and Emanuela Merla and Filippo Ballerini and Alberto Fabbri and Attilio Guarini and Vincenzo Pavone and Gerlando Quintini and Benedetta Puccini and Maria Luigia Vigliotti and Vittorio Stefoni and Enrico Derenzini and Alessandro Broccoli and Letizia Gandolfi and Federica Quirini and Beatrice Casadei and Lisa Argnani and Michele Baccarani},
  journal={Hematological oncology},
  year={2013},
  volume={31 4},
  pages={179-82}
}
Current treatments for non-Hodgkin lymphomas are not optimally effective. Among new agents, bortezomib seems to play a pivotal role in the regulation of several cell pathways involved in the development of lymphomas. After results were obtained with clinical trials, we aimed to observe treatment with bortezomib in everyday clinical practice. We performed a multicenter retrospective analysis to assess the efficacy of bortezomib in heavily pretreated (median number of previous therapies 4, range… CONTINUE READING
10 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 10 extracted citations

Similar Papers

Loading similar papers…